CH389134A
(de)
|
1960-03-15 |
1965-03-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Anthrachinonküpenfarbstoffe
|
NL293572A
(fr)
|
1962-06-07 |
|
|
|
CH478817A
(de)
|
1965-10-22 |
1969-09-30 |
Ciba Geigy |
Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
|
CH480410A
(de)
|
1967-01-09 |
1969-10-31 |
Geigy Ag J R |
Verfahren zur Herstellung von wasserlöslichen Azopyrimidinfarbstoffen
|
CA961052A
(en)
|
1967-01-12 |
1975-01-14 |
Max Schellenbaum |
N-2-ethylhexyl-n'-aryl ureas and preparation containing them
|
FR1593586A
(fr)
|
1967-10-17 |
1970-06-01 |
|
|
US3608087A
(en)
|
1968-06-21 |
1971-09-21 |
Merck & Co Inc |
Feed compositions
|
US3887329A
(en)
|
1969-05-05 |
1975-06-03 |
Ciba Geigy Ag |
Hexamethyl phosphotriamide-dye compositions
|
BE756953A
(fr)
|
1969-10-02 |
1971-04-01 |
Merck & Co Inc |
Potentialisation d'antibiotiques
|
US3686238A
(en)
|
1970-01-19 |
1972-08-22 |
Syntex Corp |
Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
|
US3852434A
(en)
|
1970-09-11 |
1974-12-03 |
Merck & Co Inc |
Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
|
US3966744A
(en)
|
1971-01-11 |
1976-06-29 |
Syva Company |
Spin labeled compounds
|
US3690834A
(en)
|
1971-01-11 |
1972-09-12 |
Syva Co |
Ligand determination with spin labeled compounds by receptor displacement
|
DE2106585A1
(de)
|
1971-02-11 |
1972-08-24 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Aminothiodiazole und Thiodiazol-Azofarbstoffe
|
CH558137A
(de)
|
1971-05-17 |
1975-01-31 |
Ciba Geigy Ag |
Mittel zur beeinflussung des pflanzenwachstums.
|
CH560197A5
(en)
|
1971-05-17 |
1975-03-27 |
Ciba Geigy Ag |
2-alkylthio-4,6-bis (subst amino)-5-nitropyrimidines - - herbicides
|
DE2226703A1
(de)
|
1972-05-25 |
1973-12-13 |
Schering Ag |
Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
|
US3966764A
(en)
|
1972-07-10 |
1976-06-29 |
Syva Company |
Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs
|
US3849420A
(en)
|
1972-10-20 |
1974-11-19 |
Dow Chemical Co |
Bis-(alkylthio-and alkylsulfonyl)-pentachloroquinolines
|
CH574206A5
(fr)
|
1972-11-16 |
1976-04-15 |
Ciba Geigy Ag |
|
DE2340569C2
(de)
|
1973-08-10 |
1982-12-02 |
Bayer Ag, 5090 Leverkusen |
Azofarbstoffe
|
DE2341925A1
(de)
|
1973-08-20 |
1975-03-06 |
Thomae Gmbh Dr K |
Neue pyrimidinderivate und verfahren zu ihrer herstellung
|
AT340933B
(de)
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
CH584739A5
(fr)
|
1973-12-21 |
1977-02-15 |
Ciba Geigy Ag |
|
US4101541A
(en)
|
1973-12-21 |
1978-07-18 |
Ciba-Geigy Corporation |
3-Cyano-1,2,4-thiadiazolyl-5-czo dyestuffs
|
FR2258841B1
(fr)
|
1974-01-29 |
1977-11-04 |
Ugine Kuhlmann |
|
AT327605B
(de)
|
1974-05-06 |
1976-02-10 |
Ciba Geigy Ag |
Mittel zur hemmung des pflanzenwachstums
|
AU492126B2
(en)
|
1974-05-14 |
1975-11-20 |
Ciba-Geigy Ag |
Nitropyrimidine derivatives
|
FR2306697A1
(fr)
|
1975-04-10 |
1976-11-05 |
Sogeras |
Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
|
US4189579A
(en)
|
1977-05-20 |
1980-02-19 |
The Dow Chemical Company |
Aminoalkylthiopurines
|
US4139705A
(en)
|
1977-05-20 |
1979-02-13 |
The Dow Chemical Company |
Pyrazolopyrimidines
|
DE2731264A1
(de)
|
1977-07-11 |
1979-02-01 |
Boehringer Mannheim Gmbh |
Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen
|
JPS6038696B2
(ja)
|
1977-12-09 |
1985-09-02 |
コニカ株式会社 |
ハロゲン化銀カラ−写真感光材料
|
US4242507A
(en)
|
1978-02-23 |
1980-12-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Sulfonic acid esters
|
DE2831580C2
(de)
|
1978-07-18 |
1980-09-18 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren und Reagens zur Bestimmung von Glycerin
|
DE2831850A1
(de)
|
1978-07-20 |
1980-02-07 |
Basf Ag |
N-arylsulfonylpyrrole, ihre herstellung und diese enthaltende therapeutische mittel
|
DE2906603A1
(de)
|
1979-02-21 |
1980-09-04 |
Boehringer Mannheim Gmbh |
N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
|
US4343804A
(en)
|
1979-03-26 |
1982-08-10 |
A. H. Robins Company, Inc. |
4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
|
EP0050671B1
(fr)
|
1980-04-28 |
1985-03-20 |
Teijin Limited |
DERIVES DE THIAZOLO(3,2-a)PYRIMIDINE, LEUR PROCEDE DE PREPARATION, ET MEDICAMENTS LES CONTENANT
|
EP0053678A1
(fr)
|
1980-12-05 |
1982-06-16 |
BASF Aktiengesellschaft |
Amino-5-phényl-1-cyano-4-pyrazoles, herbicides les contenant, leur procédé de préparation et leur application comme herbicides
|
RU938559C
(ru)
|
1980-12-12 |
1993-11-30 |
Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе |
S-Производные 5-амино-6-меркаптопиримидина, обладающие противоопухолевым и цитостатическим действием
|
DOP1981004033A
(es)
|
1980-12-23 |
1990-12-29 |
Ciba Geigy Ag |
Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
|
US4476248A
(en)
|
1983-02-28 |
1984-10-09 |
The Upjohn Company |
Crystallization of ibuprofen
|
DE3334455A1
(de)
|
1983-03-04 |
1984-09-06 |
Bayer Ag, 5090 Leverkusen |
Guanidin - derivate
|
US4612376A
(en)
|
1983-03-25 |
1986-09-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
|
ZA848275B
(en)
|
1983-12-28 |
1985-08-28 |
Degussa |
New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
JPS6157587A
(ja)
|
1984-08-29 |
1986-03-24 |
Shionogi & Co Ltd |
縮合複素環誘導体および抗潰瘍剤
|
PH22302A
(en)
|
1985-02-11 |
1988-07-22 |
Fujisawa Pharmaceutical Co |
Piperidine compounds
|
GR860542B
(en)
|
1985-03-01 |
1986-06-25 |
Duphar Int Res |
Benzoyl urea derivatives having antitumor activity
|
DE3601196A1
(de)
|
1986-01-17 |
1987-07-23 |
Merck Patent Gmbh |
1,4-dihydropyridine
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
CA1340284C
(fr)
|
1987-03-19 |
1998-12-22 |
Zeneca Inc. |
Diones cycliques avec substitution, herbicides
|
DE68926687T2
(de)
|
1988-01-11 |
1997-03-06 |
Fuji Photo Film Co Ltd |
Verfahren zur Erzeugung von extrem hochkontrastreichen negativen Bildern
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
NZ238863A
(en)
|
1990-07-19 |
1993-03-26 |
Janssen Pharmaceutica Nv |
Substituted thiazolyl and pyridinyl derivatives
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
EP0567643A4
(fr)
|
1991-01-16 |
1995-07-19 |
Yoshitomi Pharmaceutical |
Compose de pyridine utilise comme medicament selectif et nouveau compose de pyridine.
|
CA2070978A1
(fr)
|
1991-06-11 |
1992-12-12 |
William J. Greenlee |
Inhibiteurs cycliques de la renine
|
GB9114760D0
(en)
|
1991-07-09 |
1991-08-28 |
Pfizer Ltd |
Therapeutic agents
|
JPH0533359A
(ja)
|
1991-08-02 |
1993-02-09 |
Kubota Corp |
全旋回型の小型バツクホウ
|
EP0556889A1
(fr)
|
1992-02-18 |
1993-08-25 |
Duphar International Research B.V |
Méthode pour la préparation de aryl(homo)préparation
|
DE4208254A1
(de)
|
1992-03-14 |
1993-09-16 |
Hoechst Ag |
Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
|
TW237456B
(fr)
|
1992-04-09 |
1995-01-01 |
Ciba Geigy |
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
NZ314207A
(en)
|
1992-09-28 |
2000-12-22 |
Vertex Pharma |
1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
|
DE4241632A1
(de)
|
1992-12-10 |
1994-06-16 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
TW444018B
(en)
|
1992-12-17 |
2001-07-01 |
Pfizer |
Pyrazolopyrimidines
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
JPH0753546A
(ja)
|
1993-08-09 |
1995-02-28 |
Kuraray Co Ltd |
ジアリール置換複素環化合物およびその医薬用途
|
AU692484B2
(en)
|
1993-10-12 |
1998-06-11 |
Du Pont Pharmaceuticals Company |
1N-alkyl-N-arylpyrimidinamines and derivatives thereof
|
GB9400889D0
(en)
|
1994-01-18 |
1994-03-16 |
Sandoz Ltd |
Novel compounds
|
TW530047B
(en)
|
1994-06-08 |
2003-05-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
WO1996007641A1
(fr)
|
1994-09-09 |
1996-03-14 |
Nippon Shinyaku Co., Ltd. |
Derive heterocyclique et medicament
|
RO118426B1
(ro)
|
1994-11-29 |
2003-05-30 |
Dainippon Pharmaceutical Co |
Derivati de indol utilizati pentru tratarea diabetului zaharat si a obezitatii
|
AU707323B2
(en)
|
1995-03-10 |
1999-07-08 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
US5691364A
(en)
|
1995-03-10 |
1997-11-25 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
IL117659A
(en)
|
1995-04-13 |
2000-12-06 |
Dainippon Pharmaceutical Co |
Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
WO1996033994A1
(fr)
|
1995-04-28 |
1996-10-31 |
Nippon Soda Co., Ltd. |
Derives amino-substitues, leur procede de preparation et herbicide
|
EP0770080B1
(fr)
|
1995-05-12 |
1999-07-14 |
Neurogen Corporation |
Derives nouveaux de deazapurine; une nouvelle classe de ligands specifiques de crf1
|
WO1996036613A1
(fr)
|
1995-05-19 |
1996-11-21 |
Nippon Soda Co., Ltd. |
Derives d'acides benzoiques substitues, procede de production desdits derives et herbicides
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
TW438587B
(en)
|
1995-06-20 |
2001-06-07 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
KR0169813B1
(ko)
|
1995-07-12 |
1999-01-15 |
김종인 |
4-아미노-3-아실나프티리딘 유도체
|
US6248571B1
(en)
|
1995-08-31 |
2001-06-19 |
Lonza Ag |
Method of producing dihydroxypyrimidine derivatives
|
EP0940387B1
(fr)
|
1995-10-26 |
2003-05-07 |
Mitsubishi Pharma Corporation |
Composes de phenylethanolamine utiles en tant que beta3 agonistes, leurs procede et intermediaires de production
|
US5849759A
(en)
|
1995-12-08 |
1998-12-15 |
Berlex Laboratories, Inc. |
Naphthyl-substituted benzimidazole derivatives as anti-coagulants
|
USH2007H1
(en)
|
1996-01-19 |
2001-12-04 |
Fmc Corporation |
Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
|
DE19602095A1
(de)
|
1996-01-22 |
1997-07-24 |
Bayer Ag |
Halogenpyrimidine
|
DE69720429T9
(de)
|
1996-02-02 |
2004-09-23 |
Merck & Co., Inc. |
Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
|
CA2233285C
(fr)
|
1996-02-07 |
2006-07-04 |
Janssen Pharmaceutica N.V. |
Pyrazolopyrimidines en tant qu'antagonistes du recepteur de crf
|
US5948786A
(en)
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
AU3176297A
(en)
|
1996-06-25 |
1998-01-14 |
Novartis Ag |
Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
|
US6060478A
(en)
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
TW477787B
(en)
|
1996-08-27 |
2002-03-01 |
Pfizer |
Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
|
DE69736711T2
(de)
|
1996-08-28 |
2007-09-20 |
Pfizer Inc. |
Substituierte 6,5-heterobicyclische-derivate
|
DE69717474T2
(de)
|
1996-09-12 |
2003-06-26 |
Schering Ag |
Durch cyclische aminosäuren oder cyclische hydroxysäuren substituierte benzamidinderivate und deren verwendung als antikoagulantien
|
US6008234A
(en)
|
1996-09-12 |
1999-12-28 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
DZ2376A1
(fr)
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
NO980546L
(no)
|
1997-02-11 |
1998-08-12 |
Lilly Co Eli |
Farmas°ytiske midler
|
JP2001511813A
(ja)
|
1997-02-18 |
2001-08-14 |
ニューロクライン バイオサイエンシーズ,インコーポレイテッド |
Crfレセプターアンタゴニストおよびそれらに関連する方法
|
DK0977737T3
(da)
|
1997-04-22 |
2004-01-26 |
Janssen Pharmaceutica Nv |
CRF-antagonistisk quino- og quinazoline
|
EP0977759A1
(fr)
|
1997-04-22 |
2000-02-09 |
Janssen Pharmaceutica N.V. |
Thiophenopyridines antagonistes du crf
|
JPH11193277A
(ja)
|
1997-05-14 |
1999-07-21 |
Nippon Soda Co Ltd |
ピリミジン誘導体、その製法および有害生物防除剤
|
DE19737723A1
(de)
|
1997-08-14 |
1999-02-18 |
Bayer Ag |
Methoximinomethyloxadiazine
|
WO1999009026A1
(fr)
|
1997-08-14 |
1999-02-25 |
Bayer Aktiengesellschaft |
Methoximinomethyloxadiazines utilisees comme pesticides
|
NL1010018C2
(nl)
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
EP1068206A1
(fr)
|
1998-04-02 |
2001-01-17 |
Neurogen Corporation |
Derives aminoalkyle substitues de pyrrolo 2,3-b]pyridine et pyrrolo 2,3-d]pyrimidine: modulateurs de recepteurs de crf1
|
JP2000038350A
(ja)
|
1998-05-18 |
2000-02-08 |
Yoshitomi Pharmaceut Ind Ltd |
糖尿病治療薬
|
CA2339188A1
(fr)
|
1998-08-21 |
2000-03-02 |
Dupont Pharmaceuticals Company |
Isoxazolo¬4,5-d|pyrimidines comme antagonistes du crf
|
KR100658489B1
(ko)
|
1998-11-10 |
2006-12-18 |
얀센 파마슈티카 엔.브이. |
Hiv 복제를 억제하는 피리미딘
|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
ES2289610T3
(es)
|
1998-11-20 |
2008-02-01 |
Arena Pharmaceuticals, Inc. |
Receptor acoplado a proteina g humano huerfano rup3.
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
US6239126B1
(en)
|
1998-12-17 |
2001-05-29 |
American Home Products Corporation |
Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
|
CA2351400A1
(fr)
|
1998-12-17 |
2000-06-22 |
American Home Products Corporation |
Derives d'uree arylpiperidine et aryl-1,2,5,6-tetrahydropyridine presentant une activite de recepteur de 5ht1a
|
WO2000035886A2
(fr)
|
1998-12-18 |
2000-06-22 |
Axys Pharmaceuticals, Inc. |
Inhibiteurs de proteases
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
MXPA01009307A
(es)
|
1999-03-17 |
2002-07-30 |
Astrazeneca Ab |
Derivados de amida.
|
EP1040831A3
(fr)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Utilisation d'antagonistes du facteur de libération de la corticotropine pour la prévention de la mort subite
|
HUP0201291A3
(en)
|
1999-04-28 |
2002-11-28 |
Sanofi Aventis Deutschland |
Di-aryl acid derivatives as ppar receptor ligands and pharmaceutical compositions containing them
|
KR20020027463A
(ko)
|
1999-07-12 |
2002-04-13 |
우에노 도시오 |
스핀고신-1-인산 수용체 아고니스트 또는스핀고신-1-인산을 유효 성분으로서 함유하는 선유화 억제제
|
EP1074549B1
(fr)
|
1999-08-06 |
2003-11-19 |
F. Hoffmann-La Roche Ag |
Tétrahydro-benzo(d)azépines et leurs utilisations en tant qu'antagonistes du récepteur de glutamate métabotropique
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
PL354249A1
(en)
|
1999-09-17 |
2003-12-29 |
Abbott Gmbhabbott Gmbh |
Pyrazolopyrimidines as therapeutic agents
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
JP2001089452A
(ja)
|
1999-09-22 |
2001-04-03 |
Sankyo Co Ltd |
ピリミジン誘導体
|
KR100785360B1
(ko)
|
1999-09-24 |
2007-12-18 |
얀센 파마슈티카 엔.브이. |
항바이러스 조성물
|
CA2379640C
(fr)
|
1999-09-30 |
2006-11-28 |
Neurogen Corporation |
Heterocycles a substitution alkylene-diamine
|
WO2001023387A2
(fr)
|
1999-09-30 |
2001-04-05 |
Neurogen Corporation |
PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES A SUBSTITUTION ALKYLENE-DIAMINE ET PYRAZOLO[1,5-a]-1,3,5-TRIAZINES
|
ATE347553T1
(de)
|
1999-09-30 |
2006-12-15 |
Neurogen Corp |
Amino-substituierte pyrazolo 1,5-aö-1,5- pyrimidine und pyrazolo 1,5-aö-1,3,5-triazine
|
DE19947154A1
(de)
|
1999-10-01 |
2001-10-04 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
IL139197A0
(en)
|
1999-10-29 |
2001-11-25 |
Pfizer Prod Inc |
Use of corticotropin releasing factor antagonists and related compositions
|
GR990100388A
(el)
|
1999-11-09 |
2001-07-31 |
|
Φαρμακευτικος συνδυασμος αποτελουμενος απο χωριστες δοσολογικες μορφες σε συσκευασια συμμορφωσης (compliance package) ενος αναστολεα της αναγωγασης του υδροξυ-μεθυλο-γλουταρυλο συνενζυμου α (στατινης, statin) και ενος παραγωγου του φιμπρικου οξεος....
|
CA2393359A1
(fr)
|
1999-12-22 |
2001-06-28 |
Merck Frosst Canada & Co. |
Phosphonates aromatiques constituant des inhibiteurs de la phosphatase 1b (ptp-1b) de tyrosine proteique
|
DE19962936A1
(de)
|
1999-12-24 |
2001-06-28 |
Bayer Ag |
Neue beta-Aminosäureverbindungen als Integrinantagonisten
|
IL150337A0
(en)
|
1999-12-30 |
2002-12-01 |
Lundbeck & Co As H |
Phenylpiperazinyl derivatives
|
YU54402A
(sh)
|
2000-01-18 |
2005-11-28 |
Pfizer Products Inc. |
Antagonisti faktora otpuštanja kortikotropina
|
AU2001230584A1
(en)
|
2000-02-09 |
2001-08-20 |
Hokuriku Seiyaku Co., Ltd. |
1h-imidazopyridine derivatives
|
AU2001236948A1
(en)
|
2000-02-15 |
2001-08-27 |
Foster-Miller Inc. |
No voc radiation curable resin compositions
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
CA2400021A1
(fr)
|
2000-02-18 |
2001-08-23 |
Merck & Co., Inc. |
Acides aryloxyacetiques utilises en cas de diabete et de troubles lipidiques
|
KR100521735B1
(ko)
|
2000-02-25 |
2005-10-17 |
에프. 호프만-라 로슈 아게 |
아데노신 수용체 조절인자
|
KR20020089433A
(ko)
|
2000-04-12 |
2002-11-29 |
노파르티스 아게 |
유기화합물의 조합
|
ES2559273T3
(es)
|
2000-05-08 |
2016-02-11 |
Janssen Pharmaceutica Nv |
Profármacos de pirimidinas que inhiben la replicación del VIH
|
DE10024319A1
(de)
|
2000-05-17 |
2001-11-22 |
Merck Patent Gmbh |
Bisacylguanidine
|
PT1287133E
(pt)
|
2000-05-18 |
2007-03-30 |
Bayer Healthcare Ag |
Regulação do receptor acoplado à proteína g tipo dopamina humano
|
AU2001263288A1
(en)
|
2000-05-18 |
2001-11-26 |
Neurocrine Biosciences, Inc. |
Crf receptor antagonists
|
PL361361A1
(en)
|
2000-05-25 |
2004-10-04 |
F.Hoffmann-La Roche Ag |
Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
CA2413702A1
(fr)
|
2000-06-28 |
2002-01-03 |
Teva Pharmaceuticals Industries Ltd. |
Carvedilol
|
AU6871801A
(en)
|
2000-06-29 |
2002-01-14 |
Abbott Lab |
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
AR028782A1
(es)
|
2000-07-05 |
2003-05-21 |
Taisho Pharmaceutical Co Ltd |
Derivados heterociclicos tetrahidropiridino o piperidino
|
US6444685B1
(en)
|
2000-07-17 |
2002-09-03 |
Wyeth |
N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists
|
AU2001269529A1
(en)
|
2000-07-18 |
2002-01-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
Medicine comprising dicyanopyridine derivative
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
EP1305285B1
(fr)
|
2000-07-25 |
2007-05-16 |
Merck & Co., Inc. |
Indoles n-substitues utiles pour le traitement du diabete
|
AU2001284417A1
(en)
|
2000-09-05 |
2002-03-22 |
Taisho Pharmaceutical Co. Ltd. |
Hair growth stimulants
|
AU6294501A
(en)
|
2000-09-20 |
2002-04-02 |
Rtp Pharma Inc |
Spray drying process and compositions of fenofibrate
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20030224058A1
(en)
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
PE20020507A1
(es)
|
2000-10-17 |
2002-06-25 |
Schering Corp |
Compuestos no-imidazoles como antagonistas del receptor histamina h3
|
WO2002032408A2
(fr)
|
2000-10-20 |
2002-04-25 |
Novartis Ag |
Compositions
|
MXPA03003612A
(es)
|
2000-10-23 |
2003-06-19 |
Smithkline Beecham Corp |
Compuestos novedosos.
|
EP1347755A2
(fr)
|
2000-10-31 |
2003-10-01 |
Merck & Co., Inc. |
Derives d'acide benzopyranocarboxylique pour traiter le diabete et d'autres troubles lipidiques
|
KR20030060927A
(ko)
|
2000-11-03 |
2003-07-16 |
뉴로크린 바이오사이언시즈 인코퍼레이티드 |
Crf 수용체 길항제 및 이와 관련된 방법
|
US20020058026A1
(en)
|
2000-11-13 |
2002-05-16 |
Milton Hammerly |
HMG CoA reductase inhibitor medications combined wih CoEnzyme Q-10
|
WO2002039987A2
(fr)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Mise en oeuvre de bloquants des canaux anioniques des parasites de la malaria pour traiter cette maladie
|
CA2429426A1
(fr)
|
2000-11-17 |
2002-05-23 |
Takeda Chemical Industries, Ltd. |
Derives d'isoxazole
|
UA77165C2
(en)
|
2000-11-17 |
2006-11-15 |
Lilly Co Eli |
(n)-((s)-2-hydroxy-3-methyl-butyryl)-1-(l-alaninyl)-(s)-1-amino-3-methyl-4,5,6,7-tetrahydro-2h-3-benzazepin-2-one dihydrate, processes for manufacturing and pharmaceutical composition
|
ATE470662T1
(de)
|
2000-11-20 |
2010-06-15 |
Biovitrum Ab Publ |
Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
|
DE60125227T2
(de)
|
2000-12-01 |
2007-09-20 |
Astellas Pharma Inc. |
Verfahren zum screening von diabetes-heilverfahren
|
US20020137755A1
(en)
|
2000-12-04 |
2002-09-26 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
US20020107262A1
(en)
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
EP1347971B1
(fr)
|
2000-12-21 |
2006-03-01 |
Bristol-Myers Squibb Company |
Inhibiteurs thiazolyl des tyrosine kinases de la famille tec
|
CZ305202B6
(cs)
|
2001-01-26 |
2015-06-10 |
Merck Sharp & Dohme Corp. |
Farmaceutický prostředek
|
DE60234092D1
(de)
|
2001-01-30 |
2009-12-03 |
Univ Virginia |
Agonisten und antagonisten von sphingosin-1-phosphatrezeptoren
|
AU2002240235B2
(en)
|
2001-01-30 |
2006-07-06 |
Merck & Co., Inc. |
Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
|
BR0207302A
(pt)
|
2001-02-08 |
2004-02-10 |
Memory Pharm Corp |
Trifluorometilpurinas como inibidores da fosfodiesterase 4
|
EP1366012A4
(fr)
|
2001-02-09 |
2005-11-02 |
Merck & Co Inc |
Acides 2-aryloxy-2-arylalcano ques utilis s pour le traitement du diab tes et des troubles lipidiques
|
DE10110754A1
(de)
|
2001-03-07 |
2002-09-19 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
WO2002072101A1
(fr)
|
2001-03-13 |
2002-09-19 |
Bristol-Myers Squibb Pharma Company |
Ligand du recepteur de la corticoliberine, son enantiomere et ses sels pharmaceutiquement acceptables
|
EP1375463A4
(fr)
|
2001-03-29 |
2009-09-02 |
Osaka Gas Co Ltd |
Compose optiquement actif et composition de resine photosensible
|
WO2002081454A1
(fr)
|
2001-04-09 |
2002-10-17 |
Dr. Reddy's Laboratories Ltd. |
Derives d'acides aryliques et leur utilisation en medecine, procede de preparation de ces derives et compositions pharmaceutiques contenant lesdits derives
|
CN1293072C
(zh)
|
2001-04-20 |
2007-01-03 |
惠氏公司 |
作为5-羟色胺-6配体的杂环基氧基-、-硫代-和-氨基吲哚衍生物
|
KR20030096354A
(ko)
|
2001-05-10 |
2003-12-24 |
오노 야꾸힝 고교 가부시키가이샤 |
카르복실산 유도체 화합물 및 이를 유효 성분으로 하는 약제
|
DE60234338D1
(de)
|
2001-06-01 |
2009-12-24 |
Hoffmann La Roche |
Pyrimidin, triazin und pyrazinderivate als glutamatrezeptoren
|
EP1397142A4
(fr)
|
2001-06-19 |
2004-11-03 |
Bristol Myers Squibb Co |
Inhibiteurs pyrimidine de la phosphodiesterase (pde) 7
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
WO2003002544A1
(fr)
|
2001-06-26 |
2003-01-09 |
Bristol-Myers Squibb Company |
Inhibiteurs n-heterocycliques d'expression tnf-alpha
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
GB0117899D0
(en)
|
2001-07-23 |
2001-09-12 |
Astrazeneca Ab |
Chemical compounds
|
JPWO2003026661A1
(ja)
|
2001-09-14 |
2005-01-06 |
山之内製薬株式会社 |
インスリン分泌促進剤及び新規なピリミジン誘導体
|
CN1329372C
(zh)
|
2001-09-27 |
2007-08-01 |
杏林制药株式会社 |
二芳基硫醚衍生物及其加成盐和免疫抑制剂
|
US6825184B2
(en)
|
2001-10-18 |
2004-11-30 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-Disubstituted benzo-fused urea compounds
|
SE0104334D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
GB0229931D0
(en)
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
AU2002351752A1
(en)
|
2001-12-29 |
2003-07-30 |
Novo Nordisk A/S |
Combined use of a glp-1 compound and another drug for treating dyslipidemia
|
US20050043315A1
(en)
|
2002-01-02 |
2005-02-24 |
Hideo Tsutsumi |
Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
|
US20070225351A1
(en)
|
2002-01-11 |
2007-09-27 |
Lippa Arnold S |
Methods and compositions for controlling body weight and appetite
|
DE60329073D1
(de)
|
2002-01-18 |
2009-10-15 |
Merck & Co Inc |
Edg-rezeptoragonisten
|
WO2003059346A1
(fr)
|
2002-01-18 |
2003-07-24 |
The Genetics Company Inc. |
Inhibiteurs de beta-secretase
|
CA2472680A1
(fr)
|
2002-01-18 |
2003-07-31 |
Merck & Co., Inc. |
Antagonistes selectifs du recepteur s1p1/edg1
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
EP1482895A4
(fr)
|
2002-03-01 |
2005-04-27 |
Merck & Co Inc |
Aminoalkylphosphonates et composes associes utilises en tant qu'agonistes du recepteur edg
|
JP2005531508A
(ja)
|
2002-03-01 |
2005-10-20 |
メルク エンド カムパニー インコーポレーテッド |
Edg受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物
|
DE60336901D1
(de)
|
2002-03-07 |
2011-06-09 |
X Ceptor Therapeutics Inc |
Chinazolinon modulatoren von nukleinrezeptoren
|
EP1484971B1
(fr)
|
2002-03-15 |
2007-07-04 |
Ciba SC Holding AG |
Utilisation de 4-aminopyrimidines pour le traitement antimicrobien de surfaces
|
PE20040291A1
(es)
|
2002-03-22 |
2004-07-02 |
Novartis Ag |
COMBINACION QUE COMPRENDE UN INHIBIDOR DE HMG-CoA-REDUCTASA Y UN POTENCIADOR DE LA SECRECION DE INSULINA Y/O UN SENSIBILIZANTE DE INSULINA
|
AU2003225027A1
(en)
|
2002-04-16 |
2003-11-03 |
Merck And Co., Inc. |
Combination therapy using a ppar alpha/gamma agonist
|
WO2003087064A1
(fr)
|
2002-04-18 |
2003-10-23 |
Ucb, S.A. |
Composes chimiques a double activite, procedes de leur preparation et compositions pharmaceutiques
|
DE10219435A1
(de)
|
2002-05-02 |
2003-11-13 |
Bayer Cropscience Ag |
Substituierte Pyrazolo-pyrimidin-4-one
|
AU2003225305A1
(en)
|
2002-05-08 |
2003-11-11 |
Bristol-Myers Squibb Company |
Pyridine-based thyroid receptor ligands
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
JP2005531606A
(ja)
|
2002-06-10 |
2005-10-20 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子ステロール製剤およびステロールの組合せ
|
CA2488499C
(fr)
|
2002-06-10 |
2013-03-19 |
Elan Pharma International Ltd. |
Compositions nanoparticulaires comprenant des derives inhibiteurs de la hmg-coa reductase (statines), leurs combinaisons ainsi que la fabrication de ces compositions pharmaceutiques
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
CA2488498A1
(fr)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International Limited |
Formulation de polycosanol nanoparticulaires et nouvelles combinaisons de polycosanol
|
ATE494002T1
(de)
|
2002-06-14 |
2011-01-15 |
Amylin Pharmaceuticals Inc |
Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü
|
EP1549640A4
(fr)
|
2002-06-17 |
2008-08-06 |
Merck & Co Inc |
1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates et 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates utilises en tant qu'agonistes du recepteur edg
|
DE10226943A1
(de)
|
2002-06-17 |
2004-01-08 |
Bayer Ag |
Phenylaminopyrimidine und ihre Verwendung
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
SE0201976D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
DE60327211D1
(de)
|
2002-06-28 |
2009-05-28 |
Glykos Finland Oy |
Therapeutische zusammensetzungen zur verwendung bei der prophylaxe oder behandlung von durchfall
|
US20040053842A1
(en)
|
2002-07-02 |
2004-03-18 |
Pfizer Inc. |
Methods of treatment with CETP inhibitors and antihypertensive agents
|
US7071210B2
(en)
|
2002-07-02 |
2006-07-04 |
Pfizer Inc. |
CETP inhibitors in combination with antihypertensive agents and uses thereof
|
JPWO2004007472A1
(ja)
|
2002-07-10 |
2005-11-17 |
小野薬品工業株式会社 |
Ccr4アンタゴニストおよびその医薬用途
|
AU2003261204A1
(en)
|
2002-07-23 |
2004-02-09 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as kinase inhibitors
|
AU2003254053A1
(en)
|
2002-07-23 |
2004-02-09 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
US20050267133A1
(en)
|
2002-07-23 |
2005-12-01 |
Brown Matthew L |
Pyrazolopyrimidines as kinase inhibitors
|
EP1527345A2
(fr)
|
2002-07-29 |
2005-05-04 |
Axxima Pharmaceuticals AG |
Milieu et methode d'enrichissement, de purification ou d'appauvrissement de proteines de liaison a l'atp a partir d'un reservoir de proteines
|
WO2004010949A2
(fr)
|
2002-07-30 |
2004-02-05 |
University Of Virginia Patent Foundation |
Composes actifs dans la signalisation de sphingosine 1-phosphate
|
ATE400564T1
(de)
|
2002-07-30 |
2008-07-15 |
Merck & Co Inc |
Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
|
EP1539137B1
(fr)
|
2002-07-30 |
2010-05-26 |
Merck Sharp & Dohme Corp. |
Composes ppar alpha selectifs destines au traitement de la dyslipidemie et autres troubles lipidiques
|
JP2004067575A
(ja)
|
2002-08-06 |
2004-03-04 |
Yaizu Suisankagaku Industry Co Ltd |
糖尿病治療薬効果促進剤
|
EP1717220A3
(fr)
|
2002-08-08 |
2007-08-22 |
Amgen, Inc |
Ligands du récepteur vanilloide et leur utilisation dans des traitements
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
US20060167045A1
(en)
|
2002-08-21 |
2006-07-27 |
Joanne Waldstreicher |
Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist
|
RU2328483C2
(ru)
|
2002-08-29 |
2008-07-10 |
Мерк Энд Ко., Инк. |
Индолы, обладающие противодиабетической активностью
|
CA2495915A1
(fr)
|
2002-08-29 |
2004-03-11 |
Merck & Co., Inc. |
Indoles presentant un effet antidiabetique
|
US20050191612A1
(en)
|
2002-09-11 |
2005-09-01 |
Takahide Ohishi |
Method of screening insulin content enhancer
|
AU2003275242B2
(en)
|
2002-09-27 |
2010-03-04 |
Merck Sharp & Dohme Corp. |
Substituted pyrimidines
|
US7067658B2
(en)
|
2002-09-30 |
2006-06-27 |
Bristol-Myers Squibb Company |
Pyridino and pyrimidino pyrazinones
|
WO2004033431A2
(fr)
|
2002-10-04 |
2004-04-22 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles et methodes prophylactiques ou de traitement de troubles lies au metabolisme
|
WO2004033710A2
(fr)
|
2002-10-09 |
2004-04-22 |
Genaissance Pharmaceuticals, Inc. |
Haplotypes du gene itgb3 et effets de doses d'atorvastatine sur le cholesterol hdl
|
EP1551842A1
(fr)
|
2002-10-15 |
2005-07-13 |
Smithkline Beecham Corporation |
Composes de pyradazine utiles comme inhibiteurs de gsk-3
|
US7129239B2
(en)
|
2002-10-28 |
2006-10-31 |
Pfizer Inc. |
Purine compounds and uses thereof
|
EP1558609A4
(fr)
|
2002-10-30 |
2008-05-28 |
Merck & Co Inc |
Inhibiteurs de kinase
|
CA2505322A1
(fr)
|
2002-11-08 |
2004-05-21 |
Takeda Pharmaceutical Company Limited |
Agent de controle de la fonction recepteur
|
US7098235B2
(en)
|
2002-11-14 |
2006-08-29 |
Bristol-Myers Squibb Co. |
Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
|
US20040110241A1
(en)
|
2002-12-06 |
2004-06-10 |
Segal Mark S. |
Materials and methods for monitoring vascular endothelial function
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
WO2004058149A2
(fr)
|
2002-12-20 |
2004-07-15 |
Merck & Co., Inc. |
1-(amino)indanes et (1,2-dihydro-3-amino)-benzofuranes, benzothiophenes et indoles utilises en tant qu'agonistes du recepteur edg
|
US7714004B2
(en)
|
2002-12-20 |
2010-05-11 |
Bayer Pharmaceuticals Corporation |
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
|
GB0230020D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
GB0230021D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
EP1599468B1
(fr)
|
2003-01-14 |
2007-10-03 |
Arena Pharmaceuticals, Inc. |
Derives aryles et heteroaryles tri-substitues en position 1,2,3 en tant que modulateurs de metabolisme et prophylaxie et traitement de troubles lies au metabolisme
|
US20070066640A1
(en)
|
2003-01-16 |
2007-03-22 |
Emiliano Castiglioni |
Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists
|
AU2004207444B2
(en)
|
2003-01-17 |
2008-07-31 |
Merck & Co., Inc. |
N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
|
GB0301259D0
(en)
|
2003-01-20 |
2003-02-19 |
Novartis Ag |
Organic compounds
|
CA2515638A1
(fr)
|
2003-02-11 |
2004-08-26 |
Shifeng Pan |
Nouveaux composes bicycliques et compositions associees
|
TW200418829A
(en)
|
2003-02-14 |
2004-10-01 |
Avanir Pharmaceutics |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
|
US7456157B2
(en)
|
2003-02-18 |
2008-11-25 |
Kyorin Pharmaceutical Co., Ltd. |
Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators
|
CN1751038A
(zh)
|
2003-02-24 |
2006-03-22 |
艾尼纳制药公司 |
作为葡萄糖代谢调节剂的经取代芳基和杂芳基衍生物及葡萄糖代谢失调的预防和治疗
|
JP2004269468A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
JP2004269469A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
CA2520405A1
(fr)
|
2003-03-28 |
2004-10-07 |
Pfizer Products Inc. |
Derives de 1,2,3,4-tetrahydro- et 1,2 dihydro-quinoleine et 1,2,3,4-tetrahydro-quinoxaline 1,2,4-substitues, utiles comme inhibiteurs de cetp pour le traitement de l'atherosclerose et de l'obesite
|
ES2392167T3
(es)
|
2003-04-30 |
2012-12-05 |
Novartis Ag |
Derivados aminopropanol como moduladores del receptor esfingosina-1-fosfato
|
WO2004099192A2
(fr)
|
2003-04-30 |
2004-11-18 |
The Institutes Of Pharmaceutical Discovery, Llc |
Acides carboxyliques substitues par des heterocycles
|
AU2004234066B2
(en)
|
2003-04-30 |
2008-02-21 |
Novartis Ag |
Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
|
TWI494102B
(zh)
|
2003-05-02 |
2015-08-01 |
Japan Tobacco Inc |
包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合
|
DE60333546D1
(de)
|
2003-05-06 |
2010-09-09 |
Univ Palackeho |
PyrazoloÄ4,3-DÜpyrimidines, verfahren zur ihre herstellung und deren verwendung
|
SE0301368D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
US7083933B1
(en)
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
AU2004240586A1
(en)
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists
|
WO2004104205A2
(fr)
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Preparation enzymatique d'esters d'indole chiraux
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
MXPA05012460A
(es)
|
2003-05-19 |
2006-05-25 |
Irm Llc |
Compuestos y composiciones inmunosupresoras.
|
AU2004251146A1
(en)
|
2003-05-19 |
2005-01-06 |
Irm, Llc |
Immunosuppressant compounds and compositions
|
BRPI0410454A
(pt)
|
2003-05-19 |
2006-06-13 |
Irm Llc |
composições e compostos imunossupressores
|
US6987118B2
(en)
|
2003-05-21 |
2006-01-17 |
Pfizer Inc. |
Tetrahydroisoquinoline derivatives as PPAR-alpha activators
|
US20060160834A1
(en)
|
2003-06-06 |
2006-07-20 |
Fong Tung M |
Combination therapy for the treatment of hypertension
|
AU2003902882A0
(en)
|
2003-06-10 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperidyl derivatives
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
CN102417508A
(zh)
|
2003-07-14 |
2012-04-18 |
艾尼纳制药公司 |
作为新陈代谢调节剂的稠合芳基和杂芳基衍生物以及预防和治疗与其相关的病症
|
WO2005012221A1
(fr)
|
2003-08-04 |
2005-02-10 |
Ono Pharmaceutical Co., Ltd. |
Compose d'ether de diphenyle, sa methode de preparation et d'utilisation
|
WO2005016894A1
(fr)
|
2003-08-15 |
2005-02-24 |
Novartis Ag |
2, 4-pyrimidine diamines utiles dans le cadre du traitement de maladies neoplasiques, de troubles inflammatoires et de troubles du systeme immunitaire
|
CN102175786B
(zh)
|
2003-08-28 |
2013-07-17 |
诺瓦提斯公司 |
氨基丙醇衍生物
|
CN101407471A
(zh)
|
2003-08-29 |
2009-04-15 |
小野药品工业株式会社 |
能够结合s1p受体的化合物及其药物用途
|
CN100457108C
(zh)
|
2003-09-02 |
2009-02-04 |
默克公司 |
一种二肽基肽酶iv抑制剂的磷酸盐新晶体
|
WO2005023762A1
(fr)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Derives de pyrrolidine-2-carbonitrile et leur utilisation comme inhibiteurs de la dipeptidyle peptidase-iv (dpp-iv)
|
TW201127828A
(en)
|
2003-09-05 |
2011-08-16 |
Vertex Pharma |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
JPWO2005023771A1
(ja)
|
2003-09-05 |
2006-11-02 |
小野薬品工業株式会社 |
ケモカインレセプターアンタゴニストおよびその医薬用途
|
EP1699777B1
(fr)
|
2003-09-08 |
2012-12-12 |
Takeda Pharmaceutical Company Limited |
Inhibiteurs de la dipeptidylpeptidase
|
EP1697342A2
(fr)
|
2003-09-08 |
2006-09-06 |
Takeda Pharmaceutical Company Limited |
Inhibiteurs de dipeptidyle peptidase
|
AR046330A1
(es)
|
2003-09-09 |
2005-12-07 |
Japan Tobacco Inc |
Inhibidor de dipeptidilpeptidasa iv
|
CN1856307A
(zh)
|
2003-09-23 |
2006-11-01 |
默克公司 |
喹啉钾通道抑制剂
|
US20070021430A1
(en)
|
2003-09-23 |
2007-01-25 |
Chen Alex M |
Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
CA2539438A1
(fr)
|
2003-10-01 |
2005-04-14 |
Merck And Co., Inc. |
1,2,4-oxadiazoles substitues 3,5-aryle, heteroaryle ou cycloalkyle servant d'agonistes du recepteur s1p
|
WO2005033099A2
(fr)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Nouveaux inhibiteurs de dipeptidylpeptidase iv, leurs procedes de preparation et compositions les contenant
|
WO2005037215A2
(fr)
|
2003-10-14 |
2005-04-28 |
Massachusetts Institute Of Technology |
Compositions et procedes destines a ameliorer la fonction cognitive et la plasticite synaptique
|
GB0324236D0
(en)
|
2003-10-16 |
2003-11-19 |
Astrazeneca Ab |
Chemical compounds
|
PE20050444A1
(es)
|
2003-10-31 |
2005-08-09 |
Takeda Pharmaceutical |
Compuestos de piridina como inhibidores de la peptidasa
|
WO2005041899A2
(fr)
|
2003-11-03 |
2005-05-12 |
University Of Virginia Patent Foundation |
Agonistes et antagonistes du recepteur de la sphingosine-1-phosphate pouvant etre pris par voie orale
|
US7338951B2
(en)
|
2003-11-10 |
2008-03-04 |
Synta Pharmaceuticals Corp. |
Pyridine compounds
|
JPWO2005044780A1
(ja)
|
2003-11-10 |
2007-05-17 |
杏林製薬株式会社 |
アミノカルボン酸誘導体とその付加塩及びs1p受容体調節剤
|
US7674913B2
(en)
|
2003-11-12 |
2010-03-09 |
Phenomix Corporation |
Heterocyclic boronic acid compounds
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
WO2005058315A1
(fr)
|
2003-12-12 |
2005-06-30 |
Ribapharm, Inc. |
Nouveaux composes heterocycliques utilises comme inhibiteurs et presentant une activite anti-hbv
|
WO2005058849A1
(fr)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
Nouveaux inhibiteurs de dipeptidyle peptidase iv, leur procede de preparation et compositions les contenant
|
EP1697333A4
(fr)
|
2003-12-17 |
2009-07-08 |
Merck & Co Inc |
Carboxylates propanoiques 3,4-disusbstitues utilises en tant qu'agonistes du recepteur s1p (edg)
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
ATE528276T1
(de)
|
2003-12-19 |
2011-10-15 |
Ono Pharmaceutical Co |
Lysophosphatidylsäurerezeptor-antagonistische verbindungen und ihre anwendungen
|
DE10360835A1
(de)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
EP1711491A1
(fr)
|
2003-12-24 |
2006-10-18 |
Prosidion Limited |
Derives heterocycliques utilises comme agonistes des recepteurs gpcr
|
US20080227786A1
(en)
|
2004-01-16 |
2008-09-18 |
Ferlita Russell R |
Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor
|
GB0401332D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
WO2005075426A1
(fr)
|
2004-02-03 |
2005-08-18 |
Glenmark Pharmaceuticals Ltd. |
Nouveaux inhibiteurs de dipeptidyle peptidase iv, leur procedes de preparation et compositions en comportant
|
US7534798B2
(en)
|
2004-02-11 |
2009-05-19 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
EP1718604A4
(fr)
|
2004-02-24 |
2008-02-13 |
Irm Llc |
Composes et compositions d'immunosuppresseurs
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
BRPI0507944A
(pt)
|
2004-02-24 |
2007-07-24 |
Sankyo Co |
composição farmacêutica
|
JPWO2005085214A1
(ja)
|
2004-03-05 |
2008-01-17 |
萬有製薬株式会社 |
ジアリール置換複素5員環誘導体
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
PT1737820E
(pt)
|
2004-04-02 |
2008-03-17 |
Merck & Co Inc |
Processo de hidrogenação assimétrica útil para a preparação de derivados de cicloalcanoindole
|
EP1764367A1
(fr)
|
2004-04-12 |
2007-03-21 |
Sankyo Company, Limited |
Derivés de thienopyridine
|
EP1750727A2
(fr)
|
2004-04-23 |
2007-02-14 |
Exelixis, Inc. |
Modulateurs des proteines kinases et leurs methodes d'utilisation
|
DE602005011279D1
(de)
|
2004-06-04 |
2009-01-08 |
Arena Pharm Inc |
Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen
|
WO2005123677A1
(fr)
*
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
Utilisation de derives de 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa[a]pentalene a substitution 4-carbonyle comme agonistes du recepteur couple aux proteines g s1p1/edg1 et agents immunosuppresseurs
|
EP1760071A4
(fr)
|
2004-06-23 |
2008-03-05 |
Ono Pharmaceutical Co |
Composé ayant une activité de liaison aux récepteurs s1p et utilisation de celui-ci
|
CN101884781B
(zh)
|
2004-07-16 |
2012-07-18 |
杏林制药株式会社 |
用于对器官或组织的移植的排异反应或骨髓移植的移植物抗宿主反应预防或治疗的药物组合物
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
WO2006010379A1
(fr)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Nouveaux derives du thiophene utilises comme agents immunosupresseurs
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
WO2006013948A1
(fr)
|
2004-08-04 |
2006-02-09 |
Taisho Pharmaceutical Co., Ltd. |
Dérivé de traizol
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
RU2007109207A
(ru)
|
2004-08-13 |
2008-09-20 |
Прикис Фамэсьютикэлс, Инк. (US) |
Соединения-модуляторы активности рецептора сфингозин-1-фосфата (варианты), фармацевтическая композиция, содержащая указанные соединения, и способ лечения нарушения, ассоциированного со сфингозин-1-фосфатом
|
DE602005025924D1
(en)
|
2004-09-20 |
2011-02-24 |
Xenon Pharmaceuticals Inc |
Royl-coa-desaturase
|
WO2006034337A2
(fr)
|
2004-09-23 |
2006-03-30 |
Wyeth |
Derives de carbazole et de cyclopentaindole destines a traiter une infection par le virus de l'hepatite c
|
JP4797021B2
(ja)
|
2004-10-01 |
2011-10-19 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療または予防用のジペプチジルペプチダ−ゼ−iv阻害剤としてのアミノピペリジン
|
JP4862654B2
(ja)
|
2004-10-08 |
2012-01-25 |
アステラス製薬株式会社 |
芳香環縮合ピリミジン誘導体
|
JP2008515987A
(ja)
|
2004-10-12 |
2008-05-15 |
フォーブス メディ−テック(リサーチ) インコーポレーテッド |
インシュリン抵抗性及び心筋ミオパチーを治療する化合物及び方法
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
ATE397582T1
(de)
|
2004-10-22 |
2008-06-15 |
Bioprojet Soc Civ |
Neue dicarbonsäurederivate
|
US7659294B2
(en)
|
2004-10-22 |
2010-02-09 |
Merck & Co., Inc. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
WO2006052566A2
(fr)
|
2004-11-03 |
2006-05-18 |
Arena Pharmaceuticals, Inc. |
Gpr41 et modulateurs de celui-ci utilises dans le traitement de troubles lies a l'insuline
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
JP2008520692A
(ja)
|
2004-11-18 |
2008-06-19 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
複素環置換カルボン酸
|
US20080051418A1
(en)
|
2004-11-26 |
2008-02-28 |
Tsuyoshi Maekawa |
Arylalkanoic Acid Derivative
|
JP2007526251A
(ja)
|
2004-12-03 |
2007-09-13 |
テバ ファーマシューティカル インダストリーズ リミティド |
エゼチミベ多形体
|
JP2008522977A
(ja)
|
2004-12-06 |
2008-07-03 |
ユニバーシティ オブ バージニア パテント ファンデーション |
スフィンゴシン=1−リン酸のアリールアミドアナログ
|
US20070259928A1
(en)
|
2004-12-13 |
2007-11-08 |
Taishi Yoshida |
Medicinal Composition for Treating Diabetes
|
EP2592066B1
(fr)
|
2004-12-13 |
2014-12-03 |
Ono Pharmaceutical Co., Ltd. |
Dérivé d'acide aminocarboxylique et son utilisation médicale
|
JP4980928B2
(ja)
|
2004-12-24 |
2012-07-18 |
プロシディオン・リミテッド |
Gタンパク質共役受容体(gpr116)作動薬および肥満および糖尿病治療のためのその使用
|
WO2006067532A1
(fr)
|
2004-12-24 |
2006-06-29 |
Prosidion Ltd |
Agonistes du récepteur couplé aux protéines g
|
GB0428514D0
(en)
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
DOP2006000010A
(es)
|
2005-01-10 |
2006-07-31 |
Arena Pharm Inc |
Procedimiento para preparar eteres aromáticos
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
DOP2006000009A
(es)
|
2005-01-13 |
2006-08-15 |
Arena Pharm Inc |
Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
|
US20080124384A1
(en)
|
2005-01-19 |
2008-05-29 |
Blum Charles A |
Heteroaryl Substituted Piperazinyl-Pyridine Analogues
|
US7914859B2
(en)
|
2005-01-25 |
2011-03-29 |
Merck Patent Gmbh |
Mesogenic compounds, liquid crystal medium and liquid crystal display
|
EP1685841A1
(fr)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention et traitement de troubles thromboemboliques
|
EP1863463A1
(fr)
|
2005-02-14 |
2007-12-12 |
University Of Virginia Patent Foundation |
Agonistes de sphingosine-1-phosphate comportant des cycloalcanes et heterocycles substitues par des groupes amino et phenyle
|
JP5063581B2
(ja)
|
2005-03-23 |
2012-10-31 |
アクテリオン ファーマシューティカルズ リミテッド |
新規チオフェン誘導体
|
BRPI0609668A2
(pt)
|
2005-03-23 |
2011-10-18 |
Actelion Pharmaceuticals Ltd |
composto, composição farmacêutica, e, uso de um composto
|
CN101180290B
(zh)
|
2005-03-23 |
2012-12-12 |
埃科特莱茵药品有限公司 |
氢化苯并〔c〕噻吩衍生物作为免疫调节剂
|
EP1893591A1
(fr)
|
2005-06-08 |
2008-03-05 |
Novartis AG |
Oxadiazoles polycycliques ou soxazoles i et leur utilisation comme ligands recepteurs de s1p
|
CA2611446A1
(fr)
|
2005-06-09 |
2006-12-14 |
Banyu Pharmaceutical Co., Ltd. |
Agoniste de npy y2 pour une utilisation en tant qu'agent therapeutique contre une maladie s'accompagnant de diarrhee
|
TWI418350B
(zh)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
含有ppar調節劑之醫藥組成物的用途
|
RU2008101805A
(ru)
|
2005-06-24 |
2009-07-27 |
Актелион Фармасьютиклз Лтд (Ch) |
Новые производные тиофена
|
EP1909791A1
(fr)
|
2005-06-30 |
2008-04-16 |
Prosidion Limited |
Agonistes du récepteur couplé aux protéines g
|
AU2006265840B2
(en)
|
2005-07-01 |
2010-02-11 |
Irm Llc |
Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
EP1917240A1
(fr)
|
2005-08-23 |
2008-05-07 |
Irm Llc |
Composes immunosuppresseurs et compositions associees
|
CN101263135A
(zh)
|
2005-09-16 |
2008-09-10 |
艾尼纳制药公司 |
代谢调节剂和代谢相关病症的治疗
|
TW200745055A
(en)
|
2005-09-23 |
2007-12-16 |
Organon Nv |
4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
|
JPWO2007037196A1
(ja)
|
2005-09-29 |
2009-04-09 |
山本化成株式会社 |
インドリン系化合物及びその製造方法
|
SI1932522T1
(sl)
|
2005-10-07 |
2012-08-31 |
Kyorin Seiyaku Kk |
Terapevtsko sredstvo za jetrno bolezen, ki vsebuje 2-amino-1,3- propandiolni derivat kot aktivno sestavino
|
AU2006317689B2
(en)
|
2005-11-23 |
2013-07-25 |
Epix Delaware, Inc. |
S1P receptor modulating compounds and use thereof
|
AR057894A1
(es)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofeno
|
CA2635531C
(fr)
|
2005-12-29 |
2014-06-17 |
Lexicon Pharmaceutical Inc. |
Derives d'acides amines multicycliques et procedes d'utilisation de ceux-ci
|
TWI404706B
(zh)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
BRPI0621226A2
(pt)
|
2006-01-19 |
2012-07-10 |
Orchid Reseach Lab Ltd |
compostos heterociclos
|
AU2007209051A1
(en)
|
2006-01-24 |
2007-08-02 |
Actelion Pharmaceuticals Ltd |
Novel pyridine derivatives
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
TWI389683B
(zh)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
AU2007212193A1
(en)
|
2006-02-09 |
2007-08-16 |
University Of Virginia Patent Foundation |
Bicyclic sphingosine 1-phosphate analogs
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
ES2461268T3
(es)
|
2006-02-15 |
2014-05-19 |
Allergan, Inc. |
Compuestos de amida, éster, tioamida y tioléster de ácido indol-3-carboxílico que portan grupos arilo o heteroarilo que tienen actividad biológica antagonista del receptor de esfingosina-1-fosfato (S1P)
|
CN101460458A
(zh)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
JP2009527501A
(ja)
|
2006-02-21 |
2009-07-30 |
ユニバーシティ オブ バージニア パテント ファンデーション |
S1p受容体アゴニストとしてのフェニル−シクロアルキル誘導体およびフェニル−複素環誘導体
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
EP2001844A2
(fr)
|
2006-03-14 |
2008-12-17 |
Amgen, Inc |
Derives bicycliques de l'acide carboxylique utiles dans le traitement de troubles metaboliques
|
CL2007000742A1
(es)
|
2006-03-21 |
2008-01-11 |
Epix Delaware Inc |
Compuestos derivados de 2-oxoimidazol, moduladores del recptor s1p (esfingosina-1-fosfato); composicion farmceutica que los contiene; y su uso para tratar condiciones tales como rechazo de trasplante, cancer, artritis reumatoide y diabetes.
|
JP2007262009A
(ja)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
ヘテロアリール低級カルボン酸誘導体
|
AU2007236707C1
(en)
|
2006-04-03 |
2012-05-24 |
Astellas Pharma Inc. |
Hetero compound
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
EP1971862B1
(fr)
|
2006-04-11 |
2010-11-10 |
Arena Pharmaceuticals, Inc. |
Procédés d'utilisation du récepteur gpr119 pour identifier des composés utiles pour augmenter la masse osseuse chez un individu
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
EP2017263A4
(fr)
|
2006-05-09 |
2011-11-30 |
Daiichi Sankyo Co Ltd |
Derive acide carboxylique inferieur d'heteroarylamide
|
WO2007129473A1
(fr)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
Dérivé arylique bicyclique
|
EP2021338A1
(fr)
|
2006-05-09 |
2009-02-11 |
Pfizer Products Inc. |
Dérivés d'acide cycloalkylaminé et compositions pharmaceutiques à base de ceux-ci
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
WO2008008895A1
(fr)
|
2006-07-13 |
2008-01-17 |
Smithkline Beecham Corporation |
Agonistes gpr119 destinés au traitement du diabète et des troubles associés
|
JP2009545597A
(ja)
|
2006-08-01 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
スフィンゴシン−1−ホスフェート受容体(slp)のアゴニスト
|
AR062156A1
(es)
|
2006-08-01 |
2008-10-22 |
Praecis Pharm Inc |
Compuestos agonistas y selectivos del receptor s1p-1
|
WO2008019090A2
(fr)
|
2006-08-04 |
2008-02-14 |
Praecis Pharmaceuticals Incorporated |
Composés chimiques
|
US8232319B2
(en)
|
2006-08-08 |
2012-07-31 |
Kyorin Pharmaceutical Co., Ltd. |
Amino phosphate derivative and S1P receptor modulator having same as an active ingredient
|
JP2010501555A
(ja)
|
2006-08-24 |
2010-01-21 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
S1p−1受容体アゴニスト
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
US20080103123A1
(en)
|
2006-08-30 |
2008-05-01 |
Biovitrum |
New compounds
|
AU2007292347A1
(en)
|
2006-09-07 |
2008-03-13 |
Allergan, Inc. |
Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist and/or antagonist biological activity
|
TWI408139B
(zh)
|
2006-09-07 |
2013-09-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
AR062683A1
(es)
|
2006-09-07 |
2008-11-26 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de piridin-4-ilo, composicion farmaceutica que los contiene, y uso de los mismos en la preparacion de medicamentos
|
AR062677A1
(es)
|
2006-09-08 |
2008-11-26 |
Novartis Ag |
Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
|
WO2008035239A1
(fr)
|
2006-09-21 |
2008-03-27 |
Actelion Pharmaceuticals Ltd |
Dérivés phényliques et utilisation de ceux-ci en tant qu'immunomodulateurs
|
US8101634B2
(en)
|
2006-12-06 |
2012-01-24 |
Glaxosmithkline Llc |
Bicyclic compounds and use as antidiabetics
|
JP2010513272A
(ja)
|
2006-12-14 |
2010-04-30 |
メルク エンド カムパニー インコーポレーテッド |
アシルビピペリジニル化合物、そのような化合物を含む組成物、及び治療方法
|
CA2672616A1
(fr)
|
2006-12-15 |
2008-06-26 |
Abbott Laboratories |
Composes d'oxadiazole innovants
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
TW200838497A
(en)
|
2006-12-21 |
2008-10-01 |
Abbott Lab |
Sphingosine-1-phosphate receptor agonist and antagonist compounds
|
JO2701B1
(en)
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Vehicles
|
EP2125723A1
(fr)
|
2007-01-11 |
2009-12-02 |
Allergan, Inc. |
Composé amide d'acide indole-3-carboxylique 6-substitué ayant une activité biologique d'antagoniste du récepteur de sphingosine-1-phosphate (s1p)
|
WO2008091967A1
(fr)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Composés chimiques
|
WO2008097819A2
(fr)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Composés chimiques
|
SI2125797T1
(sl)
|
2007-03-16 |
2014-03-31 |
Actelion Pharmaceuticals Ltd. |
Derivati amino-piridina kot agonisti receptorja s1p1/edg1
|
EP2121648A2
(fr)
|
2007-03-21 |
2009-11-25 |
EPIX Pharmaceuticals, Inc. |
Composés modulant les récepteurs de la s1p et leur utilisation
|
WO2008128832A1
(fr)
|
2007-04-18 |
2008-10-30 |
Nicox S.A. |
Nitrodérivés non peptidiques d'inhibiteurs de la rénine destinés au traitement de maladies cardiovasculaires, rénales et chroniques du foie, des inflammations et du syndrome métabolique
|
PE20090150A1
(es)
|
2007-04-19 |
2009-05-08 |
Glaxo Group Ltd |
Compuestos derivados de oxadiazol
|
PE20090222A1
(es)
|
2007-05-04 |
2009-03-27 |
Bristol Myers Squibb Co |
Compuestos [6,6] y [6,7]-biciclicos como agonistas del receptor acoplado a la proteina g gpr119
|
EP2014653A1
(fr)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Nouveaux dérivés d'acide dicarboxylique comme agonistes du recepteur S1P1
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
WO2009019506A1
(fr)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Sulfonamides hétérocycliques ayant une activité antagoniste de edg-1
|
MX2010001446A
(es)
|
2007-08-08 |
2010-03-01 |
Merck Serono Sa |
Derivados de 6-amino-pirimidina-4-carboxamida y compuestos relacionados que se enlazan a los receptores para esfingosina 1-fosfato (s1p) para el tratamiento de esclerosis multiple.
|
ES2499018T3
(es)
|
2007-09-20 |
2014-09-26 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de GPR119
|
TW200930368A
(en)
|
2007-11-15 |
2009-07-16 |
Astrazeneca Ab |
Bis-(sulfonylamino) derivatives in therapy
|
US8637704B2
(en)
|
2007-11-28 |
2014-01-28 |
Synta Pharmaceuticals Corp. |
Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)
|
EP2222668B1
(fr)
|
2007-12-18 |
2011-11-02 |
Arena Pharmaceuticals, Inc. |
Dérivés d'acide tétrahydrocyclopenta[b]indol-3-ylcarboxylique utiles dans le traitement de troubles auto-immuns et inflammatoires
|
CA2711887A1
(fr)
|
2008-01-25 |
2009-07-30 |
Arena Pharmaceuticals, Inc. |
Derives carboxyliques dihydro-1h-pyrrolo[1,2-a]indol-1-yle agissant comme des agonistes de s1p1
|
AR070398A1
(es)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
Derivados sustituidos de indol
|
WO2009108924A2
(fr)
|
2008-02-28 |
2009-09-03 |
Solar Roofing Systems, Inc. |
Tuile photovoltaïque avec matériau anti-incendie
|
SI2278960T2
(sl)
|
2008-03-17 |
2020-02-28 |
Actelion Pharmaceuticals Ltd. |
Režim odmerjanja za selektivni agonist receptorja sip1
|
WO2009125434A2
(fr)
|
2008-04-07 |
2009-10-15 |
Cadila Healthcare Limited |
Dérivés d’oxime
|
EP2146210A1
(fr)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Procédés d'utilisation du récepteur couplé aux protéines A G pour identifier les secrétagogues de peptide YY (PYY) et composés utiles dans le traitement d'états modulés par PYY
|
KR20130132653A
(ko)
|
2008-04-07 |
2013-12-04 |
아이알엠 엘엘씨 |
Gpr119 활성의 조절제로서의 화합물 및 조성물
|
JP5837417B2
(ja)
|
2008-05-14 |
2015-12-24 |
ザ スクリプス リサーチ インスティテュート |
スフィンゴシンリン酸受容体の新規なモジュレーター
|
WO2009151626A1
(fr)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Dérivés de l’acide (1, 2, 4-oxadiazol-3-yl)indolin-1-yl carboxylique substitué pouvant être utilisés comme agonistes de s1p1
|
WO2009151621A1
(fr)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Dérivés de l’acide (1, 2, 4-oxadiazol-3-yl)indolin-1-yl carboxylique substitué utiles comme agonistes de s1p1
|
EP2326621B1
(fr)
|
2008-07-23 |
2016-06-08 |
Arena Pharmaceuticals, Inc. |
Dérivés de l acide 1,2,3,4-tétrahydrocyclopenta[b]indol-3-yle acétique substitué utilisés dans le traitement des maladies auto-immunes et inflammatoires
|
CA2733671C
(fr)
|
2008-08-27 |
2018-01-02 |
Arena Pharmaceuticals, Inc. |
Derives d'acides tricycliques substitues, utiles dans le traitement des troubles auto-immuns et inflammatoires
|
PT2379069E
(pt)
|
2008-12-22 |
2015-07-03 |
Novartis Ag |
Inalador
|
PT3409274T
(pt)
|
2008-12-22 |
2019-12-17 |
Novartis Ag |
Regime de dosagem para um agonista de recetor de s1p
|
WO2010075273A1
(fr)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Dérivés d'hétérocycles bicycliques et leurs procédés d'utilisation
|
EP2382203B1
(fr)
|
2008-12-23 |
2015-01-14 |
Merck Sharp & Dohme Corp. |
Dérivés d'hétérocycles bicycliques et leurs procédés d'utilisation
|
WO2010074271A1
(fr)
|
2008-12-26 |
2010-07-01 |
武田薬品工業株式会社 |
Agent thérapeutique pour le diabète
|
US20120016119A1
(en)
|
2009-01-22 |
2012-01-19 |
Yasunori Tsuboi |
NOVEL PYRROLO(2,3-d)PYRIMIDINE COMPOUND
|
AU2010213794A1
(en)
|
2009-02-10 |
2011-09-01 |
Abbott Laboratories |
Agonists and antagonists of the S1P5 receptor, and methods of uses thereof
|
WO2011005290A1
(fr)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Dérivés d'oxadiazole disubstitués utiles dans le traitement de troubles auto-immuns et inflammatoires
|
WO2011005295A1
(fr)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur sphingosine-1-phosphate (s1p) utiles pour le traitement de troubles associés à ceux-ci
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
AR077638A1
(es)
|
2009-07-15 |
2011-09-14 |
Lilly Co Eli |
Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
|
WO2011030139A1
(fr)
|
2009-09-11 |
2011-03-17 |
Astrazeneca Ab |
Derives de 4-(pyrimidin-2-yl)-piperazine et de 4-(pyrimidin-2-yl)-piperidine utilises en tant que modulateurs du gpr119
|
ES2759949T3
(es)
|
2009-10-29 |
2020-05-12 |
Bristol Myers Squibb Co |
Compuestos heterocíclicos tricíclicos
|
US8299059B2
(en)
|
2009-10-30 |
2012-10-30 |
Eli Lilly And Company |
Crystalline compound and a process for its preparation
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
JP2013516394A
(ja)
|
2009-12-30 |
2013-05-13 |
メディケム ソシエダ アノニマ |
医薬用途用の1−(1h−1,2,4−トリアゾール−1−イル)ブタン−2−オール誘導体、および前記1−(1h−1,2,4−トリアゾール−1−イル)ブタン−2−オール誘導体を調製するための、実質的に不定の結晶形状を有する1−(1h−1,2,4−トリアゾール−1−イル)ブタン−2−オール誘導体の使用
|
SG182610A1
(en)
|
2010-01-27 |
2012-08-30 |
Arena Pharm Inc |
Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
|
SG183416A1
(en)
|
2010-03-03 |
2012-09-27 |
Arena Pharm Inc |
Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
|
EP2556056A1
(fr)
|
2010-04-06 |
2013-02-13 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur de gpr119 et traitement de troubles associés
|
EP2598126A2
(fr)
|
2010-07-30 |
2013-06-05 |
Saint Louis University |
Méthodes de traitement de la douleur
|
KR101871011B1
(ko)
|
2010-09-22 |
2018-06-25 |
아레나 파마슈티칼스, 인크. |
Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료
|
PL2672823T3
(pl)
|
2011-02-07 |
2017-02-28 |
Biogen Ma Inc. |
Czynniki modulujące działanie receptora s1p
|
WO2012135570A1
(fr)
|
2011-04-01 |
2012-10-04 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles qui lui sont associés
|
WO2012145361A1
(fr)
|
2011-04-19 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012145604A1
(fr)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012145603A1
(fr)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012170702A1
(fr)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci
|
WO2013055910A1
(fr)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles associés
|
WO2013116657A1
(fr)
|
2012-02-03 |
2013-08-08 |
Teva Pharmaceutical Industries Ltd. |
Utilisation de laquinimod pour le traitement de patients souffrant de la maladie de crohn pour lesquels la thérapie anti-tnfα de première intention a échoué
|
US20160038506A1
(en)
|
2012-02-14 |
2016-02-11 |
Repros Therapeutics Inc. |
Selective Estrogen Receptor Modulators With Short Half-Lives and Uses Thereof
|
US8962888B2
(en)
|
2012-12-03 |
2015-02-24 |
Physical Sciences, Inc. |
Forming spherical crystal habit
|
JP5589110B1
(ja)
|
2013-03-08 |
2014-09-10 |
株式会社ポーラファルマ |
晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
|
MX2017008925A
(es)
|
2015-01-06 |
2017-10-11 |
Arena Pharm Inc |
Metodos de condiciones de tratamiento relacionadas con el receptor s1p1.
|
PT3310760T
(pt)
|
2015-06-22 |
2022-11-10 |
Arena Pharm Inc |
Sal cristalino de l-arginina de ácido (r)-2-(7-(4-ciclopentil-3-(trifluorometil)benziloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para utilização em distúrbios associados a recetores de s1p1
|
JP2020507610A
(ja)
|
2017-02-16 |
2020-03-12 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
腸管外症状を伴う炎症性腸疾患の治療のための化合物および方法
|
JP2020507611A
(ja)
|
2017-02-16 |
2020-03-12 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
原発性胆汁性胆管炎の治療のための化合物および方法
|
AU2019280822A1
(en)
|
2018-06-06 |
2021-01-07 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
US20210386706A1
(en)
|
2018-10-03 |
2021-12-16 |
Arena Pharmaceuticals, Inc. |
Methods for the treatment of scleroderma
|
AU2019387212A1
(en)
|
2018-11-30 |
2021-06-24 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
US20220142977A1
(en)
|
2019-01-08 |
2022-05-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|